期刊文献+

PEG修饰在基因递送系统中的应用:优势、不足及改善策略 被引量:4

Application of PEGylation in gene delivery systems:advantages,limitations and strategy
原文传递
导出
摘要 基因治疗是治疗多种疾病的一种强有力的手段。有效递送目的基因至病灶治疗部位是基因治疗成功的关键。目前常用的基因载体大多为阳离子纳米微粒,会引起细胞毒性和体内免疫反应,其表面通常需要PEG修饰来掩蔽部分正电荷,以降低血液循环途径中与内源性阴离子物质的非特异性结合,延长载药粒子的血液循环时间和降低毒性。然而,PEG修饰也会带来一系列的问题,如降低基因递送载体的细胞摄取、阻碍基因药物"内吞体逃逸"而降低转染效率,以及重复注射PEG化载体引起的"加速血液清除"(accelerated blood clearance,ABC)现象等。本文综述了PEG修饰应用在基因递送系统中的优势和不足,并对PEG修饰改善策略和寻找有潜力的PEG替代物进行了探讨。 Gene therapy is a new potent biomedical technology for treating various diseases. Developing a targeted gene delivery system is the crucial scientific problem for successful gene therapy. Cationic nanocarriers are usually used for gene delivery,but they may cause in vivo toxicity and immune response. In order to acquire long circulation in blood as well as reduce in vivo toxicity of the cationic nanocarriers,PEGylation is the most wide strategy,which can shield surface positive charges and reduce the non-specific interaction between endogenous protein and nanocarrier during circulation based on the presence of PEG on the surface of nanocarrier. Unfortunately,lower cellular uptake,lower transfection efficacy caused by inefficient "endosomal escape"and accelerated blood clearance( ABC) phenomenon after repeated administration are found in PEGylation nanocarriers. This review will summarize the advantages and limitations of PEGylation in gene delivery system,and discuss the possible improvement strategies or potential PEG alternatives to overcome these limitations.
机构地区 北京大学药学院
出处 《中国新药杂志》 CAS CSCD 北大核心 2016年第2期157-162,174,共7页 Chinese Journal of New Drugs
基金 国家自然科学基金(81473158 81273455)
关键词 基因递送 PEG修饰 刺激响应性连接臂 PEG替代物 gene delivery PEGylation stimuli-responsive linker PEG alternatives
  • 相关文献

参考文献39

  • 1BEHZAD M,SIAMAK SS,BEHZAD B. RNA interference and its role in cancer therapy [J]. Adv Pharm BuU,2014,4(4) :313 - 321.
  • 2MILLER VM, GOUVION CM, DAVIDSON BL, et al. Targeting Alzheimer's disease genes with RNA interference: an efficient strategy for silencing mutant alleles [ J ]. Nucleic Acids Res, 2004,32 (2) :661 - 668.
  • 3GE Q, FILIP L, BAI A, et al. Inhibition of influenza virus pro- duction in virus-infected mice by RNA interference [ J]. Proc Natl Acad Sci USA ,2004,101 (23) :8676 - 8681.
  • 4TAN SJ,KIATWUTHINON P,ROH YH,et al. Engineering nano- carriers for siRNA delivery [ J ] - Small,2011,7 (7) :841 - 856.
  • 5SOUTSCHEK J,AKINC A, BRAMLAGE B,et al. Therapeutic si- lencing of an endogenous gene by systemic administration of mod- ified siRNAs [J]. Nature,2004,432(7014):173-178.
  • 6PATIL SD,RHODES DG, BURGESS DJ. DNA-based therapeu- tics and DNA delivery systems:a comprehensive review [ J]. The AAPS Journal,2005,7( 1 ) :E61 - E77.
  • 7PARK TG, JEONG JH, KIM SW. Current status of polymeric gene delivery systems [ J ]. Adv Drug Deliv Rev, 2006,58 (4) : 467 - 486.
  • 8DASH PR, READ ML, BARRETT LB, et al. Factors affecting blood clearance and in vivo distribution of polyelectrolyte comple- xes for gene delivery [ J ]. Gene Ther, 1999,6 (4) :643 - 650.
  • 9KURSA M, WALKER GF, ROESSLER V,et al. Novel shielded transferrin-polyehtylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer [ J ]. Bioconjug Chem, 2003,14(1) :222 -231.
  • 10ENDRES T,ZHENG M, KILIC A,et al. Amphiphilic biodegrada- ble PEG-PCL-PEI triblock copolymers for FRET-capable in vitro and in vivo delivery of siRNA and quantum dots [ J]. Molecular Pharmceutics ,2014,11 (4) : 1273 - 1281.

二级参考文献6

共引文献26

同被引文献27

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部